This early-stage study tests a new radioactive tracer called [89Zr]DFO-YS5 for PET scans in 20 people with multiple myeloma. The tracer targets a protein (CD46) found on some myeloma cells, which may help doctors see cancer more clearly than standard scans. The main goals are to …
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated May 26, 2026 09:49 UTC